Clinical trials
Phase 4 Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Bronx VA Medical Center | 2 |
| Duke University | 2 |
| UCSF Benioff Children's Hospital Oakland | 2 |
| University of Kansas Medical Center | 2 |
| Baylor College of Medicine | 1 |
| Brigham and Women's Hospital | 1 |
| Columbia University | 1 |
| Foundation for Atlanta Veterans Education and Research, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 32 |
| Cardiovascular Diseases | 6 |
| Hyperlipidemias | 6 |
| Atherosclerosis | 3 |
| Dyslipidemias | 3 |
| Hyperlipoproteinemia Type II | 2 |
| Inflammation | 2 |
| Lipid Metabolism Disorders | 2 |
| Bipolar Disorder | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.